title: Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer.
abstract: To investigate the expression of CD44 in colorectal cancer and examine its association with clinicopathological features, bcl-2, p53 and long-term outcome, paraffin-embedded tumour specimens from 61 patients with Dukes stage B (AJCC/UICC stage I) and 39 patients with Dukes stage C (AJCC/UICC stage III) colorectal adenocarcinoma were assessed by immunohistochemistry. The expression of CD44, bcl-2 and p53 were correlated with 5-year follow-up. Low CD44 expression was present in 30%, moderate in 30% and extensive in 40% of cases. It was not related to patient sex and age but was related to tumour differentiation, stage and tumour site. No association was demonstrated between CD44 and bcl-2. However, there was significant evidence of an association between CD44 and p53 in 66 cases in which p53 was previously assessed. There was a trend towards increased survival in patients whose tumours expressed lower levels of CD44 protein. When entered into multivariate analysis model, which also included bcl-2 and p53, CD44 staining emerged as an indicator of poor prognosis in colorectal cancer patients.
authors.affiliation: Department of Pathologic Anatomy, Tzanio Hospital, Athens, Greece. hzavrides@hotmail.com
authors.forename: H N
authors.initials: HN
authors.lastname: Zavrides
authors.forename: A
authors.initials: A
authors.lastname: Zizi-Sermpetzoglou
authors.forename: D
authors.initials: D
authors.lastname: Panousopoulos
authors.forename: G
authors.initials: G
authors.lastname: Athanasas
authors.forename: I
authors.initials: I
authors.lastname: Elemenoglou
authors.forename: G
authors.initials: G
authors.lastname: Peros
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology; D005500:Follow-Up Studies; D006801:Humans; D018960:Hyaluronan Receptors / Q000096:biosynthesis*; D007150:Immunohistochemistry; D015999:Multivariate Analysis; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis / Q000096:biosynthesis* / Q000502:physiology; D015996:Survival Rate; D013997:Time Factors; D016159:Tumor Suppressor Protein p53 / Q000032:analysis / Q000096:biosynthesis* / Q000502:physiology
chemical_list: D018960:Hyaluronan Receptors; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53